(Q50561113)

15 March 2018

title

Sustained virological response during exenatide treatment in a patient with hepatitis C and nonalcoholic steatohepatitis. (English)

1 reference

15 March 2018

0 references

0 references

Mark Ellrichmann

1

1 reference

15 March 2018

Kirsten Vollmer

2

1 reference

15 March 2018

Henning Schrader

3

1 reference

15 March 2018

Matthias Banasch

4

1 reference

15 March 2018

Wolfgang E Schmidt

5

1 reference

15 March 2018

Juris J Meier

6

1 reference

15 March 2018

language of work or name

English

0 references

publication date

1 December 2009

1 reference

15 March 2018

The American Journal of Gastroenterology

published in

1 reference

15 March 2018

volume

104

1 reference

15 March 2018

issue

12

1 reference

15 March 2018

page(s)

3112-3114

1 reference

15 March 2018

Diagnosis, management, and treatment of hepatitis C: an update

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.444

Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.444

Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.444

Incretin mimetics as a novel therapeutic option for hepatic steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.444

Glucagon-like peptide 1(GLP-1) in biology and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.444

21 January 2018

Identifiers

DOI

10.1038/AJG.2009.444

1 reference

15 March 2018

PubMed ID

19956143

1 reference

15 March 2018